Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers

Summary

The primary objective of this trial is to investigate the relative bioavailability of BI 409306 tablets with prior 7-day intake of rifampicin tablets (Test, T) compared to BI 409306 tablets without prior administration of rifampicin (Reference, R) following oral administration in healthy male subjects. The secondary objective is the evaluation and comparison of several pharmacokinetic parameters between the treatments. The secondary objectives will be assessed by descriptive statistics.

Timeline

Start

2017-05-30

Primary completion

2017-07-11

Completion

2017-07-11

Drugs

Indications

No indication recorded.